About Repare Therapeutics, Inc.
Repare Therapeutics Inc. is a clinical-stage biotechnology company focused on the discovery and development of targeted cancer therapies based on synthetic lethality approaches. The company conducts research and development activities aimed at identifying precision oncology treatments for patients with specific genetic alterations, with a pipeline that includes small-molecule drug candidates evaluated in clinical and preclinical settings. The company was founded in 2016 and is headquartered in Montreal, Quebec, Canada.